nafamostat has been researched along with Arterial Occlusive Diseases in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moroi, K | 1 |
Shiomi, Y | 1 |
Kumano, H | 1 |
Ishimura, N | 1 |
Nishiwada, M | 1 |
Kizaki, Y | 1 |
Ueki, Y | 1 |
Yoshida, K | 1 |
Yano, M | 1 |
Matsumoto, K | 1 |
Miyake, S | 1 |
Tominaga, Y | 1 |
Eguchi, K | 1 |
Yano, K | 1 |
Kistler, EB | 1 |
Lefer, AM | 1 |
Hugli, TE | 1 |
Schmid-Schönbein, GW | 1 |
3 other studies available for nafamostat and Arterial Occlusive Diseases
Article | Year |
---|---|
[Anesthesia for a patient with heparin-induced thrombocytopenia: a case report].
Topics: Aged; Anastomosis, Surgical; Anesthesia, Epidural; Anesthesia, Inhalation; Anticoagulants; Arterial | 1997 |
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin | 1999 |
Plasma activation during splanchnic arterial occlusion shock.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzamidines; Biological Factors; Cats; Celiac | 2000 |